LIQUIDIA CORPORATION Earnings Per Share (Basic)
LIQUIDIA CORPORATION (LQDA) reported Earnings Per Share (Basic) of $0.84 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-12
- LIQUIDIA CORPORATION earnings per share, basic for the quarter ending 2026-06-30 was $0.84.
- LIQUIDIA CORPORATION earnings per share, basic for the quarter ending 2026-03-31 was $0.60.
- LIQUIDIA CORPORATION earnings per share, basic for the quarter ending 2025-12-31 was $0.17.
- LIQUIDIA CORPORATION earnings per share, basic for the quarter ending 2025-09-30 was -$0.04.
- LIQUIDIA CORPORATION earnings per share, basic for fiscal 2025 was -$0.80.
- LIQUIDIA CORPORATION earnings per share, basic for fiscal 2024 was -$1.63.
- LIQUIDIA CORPORATION earnings per share, basic for fiscal 2023 was -$1.21.
- LIQUIDIA CORPORATION earnings per share, basic for fiscal 2022 was -$0.67.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.84 10-Q · filed 2026-08-12 | $1.44 10-Q · filed 2026-08-12 | $1.62 derived: net income ÷ weighted average shares · filed 2026-08-12 | $1.58 derived: net income ÷ weighted average shares · filed 2026-08-12 | ||||
| 2026-03-31 | $0.60 10-Q · filed 2026-05-11 | $0.77 derived: net income ÷ weighted average shares · filed 2026-08-12 | $0.73 derived: net income ÷ weighted average shares · filed 2026-08-12 | $0.26 derived: net income ÷ weighted average shares · filed 2026-08-12 | ||||
| 2025-12-31 | $0.17 derived: net income ÷ weighted average shares · filed 2026-04-24 | $0.13 derived: net income ÷ weighted average shares · filed 2026-04-24 | -$0.35 derived: net income ÷ weighted average shares · filed 2026-08-12 | -$0.80 10-K · filed 2026-03-05 | ||||
| 2025-09-30 | -$0.04 10-Q · filed 2025-11-03 | -$0.52 derived: net income ÷ weighted average shares · filed 2026-08-12 | -$0.97 10-Q · filed 2025-11-03 | -$1.43 derived: net income ÷ weighted average shares · filed 2026-08-12 | ||||
| 2025-06-30 | -$0.49 10-Q · filed 2026-08-12 | -$0.94 10-Q · filed 2026-08-12 | -$1.39 derived: net income ÷ weighted average shares · filed 2026-08-12 | -$1.79 derived: net income ÷ weighted average shares · filed 2026-08-12 | ||||
| 2025-03-31 | -$0.45 10-Q · filed 2026-05-11 | -$0.91 derived: net income ÷ weighted average shares · filed 2026-08-12 | -$1.30 derived: net income ÷ weighted average shares · filed 2026-08-12 | -$1.68 derived: net income ÷ weighted average shares · filed 2026-08-12 | ||||
| 2024-12-31 | -$0.45 8-K · filed 2025-05-08 | -$0.85 derived: net income ÷ weighted average shares · filed 2026-03-05 | -$1.23 derived: net income ÷ weighted average shares · filed 2026-03-05 | -$1.63 10-K · filed 2026-03-05 | -$1.66 10-K · filed 2025-03-19 | |||
| 2024-09-30 | -$0.40 10-Q · filed 2025-11-03 | -$0.30 10-Q · filed 2024-11-13 | -$0.77 derived: net income ÷ weighted average shares · filed 2025-11-03 | -$1.17 10-Q · filed 2025-11-03 | -$1.20 10-Q · filed 2024-11-13 | -$1.59 derived: net income ÷ weighted average shares · filed 2026-03-05 | ||
| 2024-06-30 | -$0.38 10-Q · filed 2025-08-12 | -$0.37 10-Q · filed 2024-08-07 | -$0.78 10-Q · filed 2025-08-12 | -$0.91 10-Q · filed 2024-08-07 | -$1.19 derived: net income ÷ weighted average shares · filed 2026-03-05 | -$1.44 derived: net income ÷ weighted average shares · filed 2026-03-05 | ||
| 2024-03-31 | -$0.40 8-K · filed 2025-05-08 | -$0.54 10-Q · filed 2024-05-13 | -$0.82 derived: net income ÷ weighted average shares · filed 2026-03-05 | -$1.07 derived: net income ÷ weighted average shares · filed 2026-03-05 | -$1.43 derived: net income ÷ weighted average shares · filed 2026-03-05 | |||
| 2023-12-31 | -$0.43 8-K · filed 2025-05-08 | -$0.66 derived: net income ÷ weighted average shares · filed 2026-03-05 | -$1.03 derived: net income ÷ weighted average shares · filed 2026-03-05 | -$1.21 10-K · filed 2026-03-05 | ||||
| 2023-09-30 | -$0.24 8-K · filed 2025-05-08 | -$0.61 derived: net income ÷ weighted average shares · filed 2025-05-08 | -$0.79 10-Q · filed 2024-11-13 | -$0.89 derived: net income ÷ weighted average shares · filed 2026-04-24 | ||||
| 2023-06-30 | -$0.36 8-K · filed 2025-05-08 | -$0.54 10-Q · filed 2024-08-07 | -$0.65 derived: net income ÷ weighted average shares · filed 2026-04-24 | -$0.79 derived: net income ÷ weighted average shares · filed 2026-04-24 | ||||
| 2023-03-31 | -$0.18 8-K · filed 2025-05-08 | -$0.28 derived: net income ÷ weighted average shares · filed 2026-04-24 | -$0.42 derived: net income ÷ weighted average shares · filed 2026-04-24 | -$0.58 derived: net income ÷ weighted average shares · filed 2026-04-24 | ||||
| 2022-12-31 | -$0.10 derived: net income ÷ weighted average shares · filed 2026-04-24 | -$0.24 derived: net income ÷ weighted average shares · filed 2026-04-24 | -$0.39 derived: net income ÷ weighted average shares · filed 2026-04-24 | -$0.67 10-K · filed 2024-03-13 | ||||
| 2022-09-30 | -$0.14 10-Q · filed 2023-11-07 | -$0.29 derived: net income ÷ weighted average shares · filed 2023-11-07 | -$0.58 10-Q · filed 2023-11-07 | -$0.80 derived: net income ÷ weighted average shares · filed 2023-11-07 | ||||
| 2022-06-30 | -$0.15 10-Q · filed 2023-08-10 | -$0.44 10-Q · filed 2023-08-10 | -$0.66 derived: net income ÷ weighted average shares · filed 2023-11-07 | -$0.81 derived: net income ÷ weighted average shares · filed 2023-11-07 | ||||
| 2022-03-31 | -$0.30 10-Q · filed 2023-05-08 | -$0.53 derived: net income ÷ weighted average shares · filed 2023-11-07 | -$0.67 derived: net income ÷ weighted average shares · filed 2023-11-07 | -$0.80 derived: net income ÷ weighted average shares · filed 2023-11-07 | ||||
| 2021-12-31 | -$0.22 derived: net income ÷ weighted average shares · filed 2023-03-20 | -$0.36 derived: net income ÷ weighted average shares · filed 2023-03-20 | -$0.49 derived: net income ÷ weighted average shares · filed 2023-03-20 | -$0.70 10-K · filed 2023-03-20 | ||||
| 2021-09-30 | -$0.14 10-Q · filed 2022-11-08 | -$0.27 derived: net income ÷ weighted average shares · filed 2022-11-08 | -$0.47 10-Q · filed 2022-11-08 | |||||
| 2021-06-30 | -$0.13 10-Q · filed 2022-08-11 | -$0.33 10-Q · filed 2022-08-11 | ||||||
| 2021-03-31 | -$0.21 10-Q · filed 2022-05-12 | |||||||
| 2020-12-31 | -$1.76 10-K · filed 2022-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |